COMP <GO>
NMTC vs PLSM // EV/EBITDA & P/E VALUATION
NeuroOne Medical Technologies Corporation (NASDAQ) VS. Pulsenmore Ltd. (NASDAQ) • 15-METRIC TALLY: NMTC 1
— PLSM 1
■ METRIC PARITY
LAST: $0.97 (+12.96%) • MKT CAP: $8.8M
valuation
—
LAST: $1.62 (-8.48%) • MKT CAP: $10.5M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NMTC VS. PLSM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NMTC | PLSM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -46.50% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -39.60% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 163.50% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.1 | 31.9 | +8.15 | NMTC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.8M | $10.5M | -$1.7M | PLSM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NMTC REV | PLSM REV | NMTC GROSS % | PLSM GROSS % | NMTC FCF | PLSM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.1M | — | 56.5% | — | -$2.9M | — |
| FY 2024 | $3.5M | — | 31.3% | — | -$11.1M | — |
| FY 2023 | $2.0M | — | — | — | -$12.9M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NMTC // BETA —
PLSM // BETA —